Medi-Tech Insights Get in touch

Global Large Molecule Drug Substance CDMO Market Size & Trends Report Segmented by Service (Contract Manufacturing, Contract Development), Source (Mammalian, Microbial), End-user (CRO, Biotech Companies), & Regional Forecast to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

  • Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2025-2026)
  • Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  • Executive Summary
    • Large Molecule Drug Substance CDMO Market Snapshot (2025-2030)
    • Segment Overview
    • Regional Snapshot
    • Competitive Insights
  • Increasing FDA & EMA approvals for large molecule drugs
  • Rising incidence of chronic and infectious diseases
  • Growing investments in biologics manufacturing by pharma and biotech companies
  • Expanding biotech sectors in emerging markets
  • Restraints
    • High costs associated with advanced manufacturing technologies
    • Complex analytical characterization of biologics
    • Stringent government regulatory regulations
  • Opportunities
    • Increasing focus on personalized medicine
    • Expansion in cell and gene therapy manufacturing
    • Increased strategic collaborations & partnerships between pharmaceutical companies and CDMOs
      • Key Market Trends
        • Growing usage of AI, machine learning, and predictive analytics in biomanufacturing
        • Rising demand for mRNA-based therapeutics
        • Adoption of single-use bioprocessing technologies
      • Unmet Market Needs
      • Industry Speaks
    • Global Large Molecule Drug Substance CDMO Market Size & Forecast (2023-2030), By Service, USD Million
      • Introduction
      • Contract Manufacturing
        • Clinical
        • Commercial
      • Contract Development
        • Cell Line Development
        • Process Development
    • Global Large Molecule Drug Substance CDMO Market Size & Forecast (2023-2030), By Source, USD Million
      • Introduction
      • Mammalian
      • Microbial
      • Others
    • Global MO Market Size & Forecast (2023-2030), By End-user, USD Million
      • Introduction
      • CRO
      • Biotech Companies
      • Others
    • Global Large Molecule Drug Substance CDMO MarketSize & Forecast (2023-2030), By Region, USD Million
      • Introduction
      • North America Large Molecule Drug Substance CDMO MarketSize & Forecast (2023-2030), By Country, USD Million
        • US
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Canada
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • 30), By Country, USD Million
        • UK
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Germany
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • France
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Italy
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Spain
          • Market Size & Forecast, By End-user (USD Million)
        • Rest of Europe
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
      • Asia Pacific (APAC) Large Molecule Drug Substance CDMO MarketSize & Forecast (2023-2030), By Country, USD Million
        • China
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • Japan
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
        • India
          • Market llion)
          • Market Size & Forecast, By End-user (USD Million)
        • Rest of Asia Pacific
          • Market Size & Forecast, By Service (USD Million)
          • Market Size & Forecast, By Source (USD Million)
          • Market Size & Forecast, By End-user (USD Million)
      • Latin America (LATAM) Large Molecule Drug Substance CDMO MarketSize & Forecast (2023-2030), USD Million
        • Market Size & Forecast, By Service (USD Million)
        • Market Size & Forecast, By Source (USD Million)
        • Market Size & Forecast, By End-user (USD Million)
      • Middle East & Africa (MEA) Large Molecule Drug Substance CDMO MarketSize & Forecast (2023-2030), USD Million
        • Market Size & Forecast, By Service (USD Million)
        • Market Size & Forecast, By Source (USD Million)
        • Market Size & Forecast, By End-
          • Key Players and their Competitive Positioning
            • Key Player Comparison
            • Segment-wise Player Mapping
            • Market Share Analysis (2024)
            • Company Categorization Matrix
              • Dominants/Leaders
              • New Entrants
              • Emerging Players
              • Innovative Players
          • Key Strategies Assessment, By Player (2022-2025)
            • New Service Launches
            • Partnerships, Agreements, & Collaborations
            • Mergers & Acquisitions
            • Geographic Expansion
        • Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
          • Eurofins Scientific
          • WuXi Biologics
          • Samsung Biologics
          • Catalent, Inc.
          • Rentschler Biopharma SE
          • AGC Biologics
          • Recipharm AB
          • Siegfried Holding AG
          • Boehringer Ingelheim
          • FUJIFILM Diosynth Biotechnologies
          • Other Prominent Players

        Note: *Indicative list

        **For liste

    Related Reports

    View All Research Reports